Opens in a new tab

Roche Diabetes Care v Tandem Diabetes Care (CFI, 9 September 2024)

Date9 September 2024
CourtCFI
DivisionHamburg (DE) Local Division
Type of actionGeneric application
Registry referenceApp_28467/2024 · ORD_28786/2024
PartiesTandem Diabetes Care, Inc., Tandem Diabetes Care Europe B.V.,

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 9 September 2024 (UPC_CFI_88/2024, ACT_10800/2024, ORD_28786/2024), the Hamburg Local Division (S. Klepsch, presiding and judge-rapporteur, S. Schilling, T. Zhilova, G. Checcacci) dismissed the request by Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V. to stay Roche Diabetes Care’s infringement action on EP 2 196 231 pending the revocation action they had brought on 30 November 2023 before the Paris Central Division. It also refused to hear infringement and validity together in Hamburg, and granted leave to appeal.

Question

Should a local division stay infringement proceedings where an earlier revocation action is pending before the Central Division?

Decision

The division exercises the discretion conferred by Art. 33(3) and (5) UPCA and Rule 75 RoP to proceed. Following the Court of Appeal’s order of 28 May 2024, a stay must in principle be ruled out, having regard to the right to an effective remedy within a reasonable time and the aim of a final oral hearing within one year. The risk of irreconcilable decisions does not require a stay, as the panel deciding last can take the Central Division’s decision into account. The claimant’s interest prevails, the outcome of the revocation action being uncertain in timing and substance, and the parties to the two sets of proceedings are not identical. The division need not assess the likelihood of invalidity and, for the time being, does not follow the judge-rapporteur’s provisional view of 14 June 2024 that it could hear the defendants’ revocation action.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts. 33(3) and (5) and 73(2)(b)(ii)
Rules of Procedure
Rules 37, 75, 220.2 and 295
Case law cited
Carrier v BITZER Electronics, Court of Appeal, 28 May 2024 (UPC_CoA_22/2024)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La division locale de Hambourg refuse de surseoir à statuer sur l'action en contrefaçon dans l'attente de l'action en nullité pendante devant la division centrale, refuse d'instruire ensemble les deux actions et autorise l'appel.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 196 231
System for ambulatory drug infusion comprising a filling apparatus for flexible containers
recorded proprietor: F Hoffmann La Roche AG et Roche Diagnostics GmbH
Mentioned in the analysis (role not qualified)
Also mentioned in 9 other decision(s): Tandem Diabetes Care Europe v Roche Diabetes Care (CFI, 18 December 20 · Tandem Diabetes Care Europe v Roche Diabetes Care (CoA, 3 July 2025) · Tandem Diabetes Care Europe v Roche Diabetes Care (CoA, 5 June 2025) · Roche Diabetes Care v Tandem Diabetes Care (CFI, 26 July 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, 27 June 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, 10 May 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9062/2024, 20 Feb · Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9060/2024, 20 Feb
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.